We recently compiled a list of the 14 Worst 52-Week High Stocks to Buy According to Short Sellers. In this article, we are going to take a look at where TG Therapeutics Inc (NASDAQ:TGTX) stands ...
NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then released ...
NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then released ...
Q1 EPS of $0.03 beats the estimate of -$0.17; revenue hit $120.86 million, up from $63.47 million YoY. Briumvi U.S. sales hit $119.7 million; TG Therapeutics ups 2025 guidance to $560 million from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback